Katsuhisa Enomoto Selected Research

Katsuhisa Enomoto Research Topics

Disease

70	Breast Neoplasms (Breast Cancer) 11/2022 - 10/2005
34	Neoplasms (Cancer) 10/2018 - 08/2005
29	Neoplasm Metastasis (Metastasis) 11/2022 - 10/2004
18	Ductal Carcinoma 04/2018 - 10/2005
9	Carcinoma (Carcinomatosis) 10/2018 - 11/2006
6	Thyroid Neoplasms (Thyroid Cancer) 02/2018 - 11/2008
5	Hemorrhage 10/2017 - 11/2008
4	Lymphatic Metastasis 01/2018 - 11/2012
3	Mucinous Adenocarcinoma (Mucinous Carcinoma) 11/2015 - 11/2013
3	Noninfiltrating Intraductal Carcinoma (DCIS) 11/2013 - 11/2010
2	Disease Progression 11/2022 - 03/2011
2	Primary Hyperparathyroidism 12/2019 - 04/2007
2	Neuroendocrine Carcinoma 04/2018 - 11/2017
2	Lobular Carcinoma 01/2018 - 11/2012
2	Margins of Excision 11/2014 - 11/2010
2	Phyllodes Tumor (Cystosarcoma Phylloides) 11/2014 - 11/2010
2	Jaundice (Icterus) 11/2006 - 10/2005
1	Adenoma (Adenomas) 12/2019
1	Ulcer 02/2018
1	Pleural Effusion (Pleural Effusions) 10/2017
1	Laryngeal Edema 11/2016
1	Male Breast Neoplasms (Male Breast Cancer) 11/2016
1	Obesity 10/2016
1	Triple Negative Breast Neoplasms 03/2016
1	Breast Ductal Carcinoma 11/2015
1	Weight Loss (Weight Reduction) 11/2015
1	Lymphopenia (Lymphocytopenia) 10/2015
1	Carcinogenesis 03/2015
1	Fibroadenoma 11/2014
1	Oxyphilic Adenoma (Oncocytoma) 11/2014
1	Renal Insufficiency (Renal Failure) 11/2014
1	Hypercalcemia (Milk Alkali Syndrome) 11/2014
1	Sarcoma (Soft Tissue Sarcoma) 11/2014

Drug/Important Bio-Agent (IBA)

29	Estrogen ReceptorsIBA 10/2018 - 11/2007
24	Progesterone Receptors (Progesterone Receptor)IBA 04/2018 - 11/2007
21	Proteins (Proteins, Gene)FDA Link 01/2018 - 10/2005
15	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 10/2018 - 10/2004
10	Hormones (Hormone)IBA 10/2018 - 11/2008
10	Paclitaxel (Taxol)FDA LinkGeneric 10/2017 - 11/2008
6	Toremifene (Fareston)FDA Link 10/2014 - 11/2008
5	eribulin FDA Link 11/2022 - 11/2013
5	Aromatase InhibitorsIBA 10/2017 - 11/2009
5	ErbB Receptors (EGF Receptor)IBA 03/2016 - 11/2012
4	Letrozole (Femara)FDA LinkGeneric 10/2018 - 11/2012
4	Bevacizumab (Avastin)FDA Link 02/2018 - 10/2014
4	Fulvestrant (Faslodex)FDA Link 01/2018 - 10/2015
4	human ERBB2 proteinIBA 11/2013 - 11/2012
4	Trastuzumab (Herceptin)FDA Link 11/2012 - 11/2006
3	Parathyroid Hormone (Parathormone)IBA 12/2019 - 04/2007
3	Tumor Biomarkers (Tumor Markers)IBA 01/2018 - 11/2012
3	taxaneIBA 01/2018 - 11/2007
3	130-nm albumin-bound paclitaxelIBA 10/2017 - 11/2012
3	immunosuppressive acidic proteinIBA 10/2016 - 10/2004
3	Docetaxel (Taxotere)FDA Link 11/2012 - 11/2008
2	CalciumIBA 12/2019 - 04/2007
2	Estrogens (Estrogen)FDA Link 04/2018 - 11/2013
2	Capecitabine (Xeloda)FDA Link 01/2018 - 11/2015
2	AnthracyclinesIBA 01/2018 - 10/2005
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2017 - 11/2012
2	Epirubicin (Ellence)FDA LinkGeneric 10/2017 - 11/2012
2	Ointments (Pastes)IBA 10/2017 - 10/2016
2	Mohs' pasteIBA 10/2017 - 10/2016
2	Pharmaceutical PreparationsIBA 11/2012 - 10/2005
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 04/2011 - 01/2011
2	Tamoxifen FDA LinkGeneric 04/2011 - 01/2011
1	palbociclibIBA 10/2018
1	Therapeutic UsesIBA 10/2018
1	SynaptophysinIBA 04/2018
1	Chromogranin AIBA 04/2018
1	Actins (F Actin)IBA 11/2016
1	lenvatinibIBA 11/2016
1	SteroidsIBA 11/2016
1	C-Reactive ProteinIBA 10/2016
1	Androgen Receptors (Androgen Receptor)IBA 03/2016
1	Keratin-5 (Keratin 5)IBA 03/2016
1	Coloring Agents (Dyes)IBA 11/2015
1	Dihydrotachysterol (AT 10)IBA 11/2015
1	Phenobarbital (Luminal)FDA Link 03/2015
1	ClaudinsIBA 03/2015
1	Messenger RNA (mRNA)IBA 03/2015
1	Claudin-3IBA 03/2015
1	CateninsIBA 03/2015
1	Growth Factor ReceptorsIBA 03/2015
1	Glycoproteins (Glycoprotein)IBA 03/2015
1	Formaldehyde (Formol)FDA Link 03/2015
1	ParaffinIBA 03/2015
1	Cadherins (E-Cadherin)IBA 03/2015
1	Claudin-4IBA 03/2015

Therapy/Procedure

46	Therapeutics 10/2018 - 08/2005
26	Drug Therapy (Chemotherapy) 10/2018 - 10/2005
12	Segmental Mastectomy (Lumpectomy) 04/2019 - 11/2011
10	Lymph Node Excision (Lymph Node Dissection) 04/2019 - 11/2007
7	Radiotherapy 10/2013 - 10/2005
4	Mastectomy (Mammectomy) 04/2019 - 11/2010
3	Neoadjuvant Therapy 10/2015 - 11/2012
3	Local Anesthesia 11/2011 - 11/2009
2	Palliative Care (Palliative Therapy) 10/2017 - 10/2016
2	General Anesthesia 11/2011 - 11/2009
1	Adjuvant Chemotherapy 03/2016
1	Lasers (Laser) 03/2015